I think that depends on Vyvanse approval decision by FDA.
I’d like to see both Codeine & Percocet launched this calendar year, but if all we get is a Codeine launch and a Vyvanse approval, that would be amazing, knowing launch would be soon. Vyvanse is what we want to go off without a hitch, so I’m ok on it taking a little longer. Slow down to speed up. Sounds like they have everything in order for a near-term launch if FDA approved, but we’ll see.
Market Data 
Markets 
AI
